Curcuma longa (C. longa), a common Indian dietary pigment and spice, has been used therapeutically in traditional folk medicine for a wide range of ailments, including wound healing, urinary tract infection, and liver ailments.
Curcuma longa Extract Protects against Gastric Ulcers by Blocking H 2 Histamine Receptors
Curcuma longa has been commonly used as a traditional remedy for a variety of symptoms such as inflammation, gastritis and gastric ulcer. When C. longa extract was administered per os to pylori-ligated rat stomachs, it reduced gastric acid secretion and protected against the formation of gastric mucosal lesions. We therefore tested whether C. longa extract inhibits gastric ulcers by blocking the H 2 histamine receptor. Dimaprit, a H 2 histamine receptor agonist, induced intracellular cAMP production in U937 and HL-60 promyelocytes. Pretreatment with C. longa extract significantly blocked dimaprit-induced cAMP production in a concentration dependent manner, but had no effect on the elevation of cAMP levels triggered by isoproterenol-induced b b 2 -adrenoceptor activation in U937 cells. To identify the active component(s) of C. longa extract, we sequentially fractionated it by extraction with ethyl acetate, n-butanol and water. We found that the ethyl acetate extract showed the most potent H 2 R antagonistic effect against dimaprit-induced cAMP production. However, curcumin, a major component of C. longa extract, showed no H 2 R blocking effect. C. longa ethanol extract and ethylacetate extract also blocked the binding of [ and the reaction was quickly terminated by three repeated cycles of freezing and thawing. The samples were then centrifuged at 2500ϫg for 5 min at 4°C. ]-labeled cAMP (5 mCi) and 100 ml binding protein for 2 h at 4°C. Separation of protein-bound cAMP from unbound cAMP was achieved by adsorption of free cAMP onto charcoal (100 ml) followed by centrifugation at 12000ϫg at 4°C. The 200 ml supernatant was then placed into an Eppendorf tube containing 1.2 ml scintillation cocktail to measure radioactivity. The cAMP concentration in the sample was determined based on a standard curve and expressed as picomoles per number of cells.
[ 3 H]-Tiotidine Binding The binding of [ 3 H]-tiotidine to intact HL-60 cells was quantified by the method described in previous report 9) with some modification. Triplicate assays were performed in polyethylene tubes in 50 mM Tris-HCl, pH 7.4. 6 cells/tube in the absence or presence of ranitidine or C. longa extracts in a total volume of 200 ml. After 40 min at 4°C, incubation was stopped by dilution with 3 ml of ice-cold 50 mM Tris-HCl, pH 7.4; rapid filtration onto Whatman GF/B glass-fibers filters was performed under reduced pressure, followed by three washes with 3 ml of ice-cold buffer. The amount of bound radioactivity was measured in a liquid scintillation cocktail. Specific binding was defined as the difference in the amount of radioactivity bound in the absence and presence of 1 mM unlabeled tiotidine.
Measurement of Gastric Acid Secretion and Gastroprotective Activity in Vivo The pylorus-ligated rat model first described by Shay et al. was used with some modification. 10 ) SD rats weighing 200-250 g were used. Rats were deprived of food, but not water, for 18-24 h prior to each experiment. The test substances (vehicle, ranitidine, C. longa extract) dissolved in saline were administered orally (per os). After 1 h, rats were anesthetized by light ether, a small abdominal incision was made, the pylorus was ligated. The animals were sacrificed 8 h after ligation of the pylorus, the stomach was clamped at the oesophageal and duodenal junctions and then rapidly removed. The gastric juice was collected and the excised stomach was then filled with 15 ml of 4% formalin. After 24 h, the fixed stomach was opened along the greater curvature, gently rinsed in saline, and then pinned open to expose the gastric mucosa. The haemorrhagic and ulcerative lesions were counted and measured with a light microscope by an observer who was blinded to the treatment. The ulcer index was then calculated as the sum of the length of all lesions as previously described.
11) The ulcer index was determined in six animals in each animal group. The gastric content was placed in tubes for later centrifugation at 1500ϫg for 30 min in a refrigerated centrifuge. Total acidity was determined by simple titration with 0.01 N NaOH using phenol-red as acid-base indicator.
Histological Examination The histological study of the stomach was performed following evaluation of the ulcer index. Samples of the corpus were excised and transferred to fresh formalin and later processed by routine techniques prior to embedding in paraffin. Sections (5 mm thick) were mounted on glass slides and stained with haematoxylin and eosin. Coded slides were examined by an experienced pathologist blinded to the treatment.
Statistical Analysis All quantitative data are expressed as meanϮS.E.M. Comparisons between two groups were performed using Student's unpaired t-test, and comparison among groups more than two was carried out using one-way analysis of variance (ANOVA). Differences were considered to be significant when the degree of confidence in the significance was 95% of better (pϽ0.05).
RESULTS

Effect of C. longa on Gastric Acid Secretion and the Formation of Gastric Mucosal Lesions
Using the Shay ulcer model, which causes gastric hypersecretion, 12) we investigated the effects of C. longa extract on gastric acid secretion and mucosal injury, and compared them with the effects of ranitidine. Ranitidine has been shown to have a marked anti-ulcer effect and has been used in the treatment and prevention of a variety of gastrointestinal disorders associated with gastric acid secretion. 13) Histopathological examination of gastric lesions showed discontinuation of the surface epithelium in the vehicle treated group. In contrast, C. longa extract protected the gastric mucosal layer as effectively as ranitidine (Fig. 1A) . Using the pylori-ligated rat model, we found that per os administration of C. longa extract significantly inhibited gastric acid (Fig. 1D) , gastric juice secretion (Fig. 1B) , and ulcer formation (Fig. 1C) , comparable to the effects of ranitidine. The ethanol extract of C. longa reduced the volume of gastric acid secreted after pylorus ligature, indicating that this may be the mechanism by which C. longa extract protects the gastric mucosa. C. longa Extract Inhibits H 2 Histamine Receptor (H 2 R)-Mediated Intracellular cAMP Production in U937 and HL-60 Promyelocytes H 2 R is the primary target of anti-ulcer drugs, 14) and H 2 R antagonists have been shown to inhibit gastric acid secretion in many animal model systems. 13, 15, 16) H 2 R is also expressed not only on gastric parietal cell but also on immune cells, 17) including the U937 and HL-60 promyelocytic cell lines, which have been widely used as model systems for H 2 histamine receptor activity. 9, 18) We therefore tested the effect of dimaprit, a selective H 2 R agonist, on the generation of cAMP in U937 and HL-60 cells. Application of various concentrations of dimaprit triggered cAMP production in a concentration-dependent manner ( Fig.  2A) , and with an EC 50 of 5.5Ϯ0.9 mM. The effect of 10 mM dimaprit was inhibited by 10 mM of the specific H 2 receptor antagonist, ranitidine (10 mM), and by C. longa extract in a concentration-dependent manner (Fig. 2B, closed circle) . In addition, C. longa extract also suppressed histamine-induced cAMP production in a concentration-dependent manner (Fig.  2B ). Since C. longa extract may block Gsa-protein activity rather than H 2 R, we tested the involvement of Gsa-protein in the activity of C. longa extract by treating the U937 cells with isoproterenol (500 nM), an agonist of the Gsa-protein coupled b 2 -adrenoceptor, following treatment with C. longa extract. 19, 20) C. longa did not affect isoproterenol-induced cAMP production (Fig. 2B, closed box) , indicating that the inhibitory effect of C. longa extract on the dimaprit-induced cAMP generation was through direct inhibition of H 2 R. We could not detect significant cellular damage (by MTT assay) in cells treated with vehicle or pretreated with ranitidine or C. longa extract (data not shown), suggesting that the C. longa inhibition of dimaprit-induced cAMP responses was not due to cell death.
Effects of the Ethyl Acetate Fraction of C. longa and Curcumin on H 2 R Signaling We subjected the 80% ethanol extract of C. longa to successive solvent extractions 21) and obtained the ethyl acetate (EA), n-buthanol (nButa), and water extracts. To determine the H 2 R blocking activity of these extracts, U937 cells were pretreated with each extract, and the cells were subsequently treated with dimaprit. We found that both the EA and n-Buta extracts significantly inhibited dimaprit-induced cAMP production, but the effect of EA extract was more pronounced (Fig. 3A) . Since the active constituent(s) may have accumulated in the EA extract, we compared the H 2 R inhibitory activity of the EA and ethanol extracts of C. longa. We found that both extracts significantly inhibited H 2 R in a concentration-dependent manner (Fig. 3B) , with IC 50 s of 6.0Ϯ0.5 mg/ml and 30.00Ϯ0.78 mg/ml, respectively. These findings indicate that substance in C. longa that acts H 2 R is probably contained in the EA extract. Since curcumin is the major component of C. longa, 22) we investigated the effect of curcumin on dimapritinduced H 2 R signaling. Curcumin, however, showed no significant effect on H 2 R activity (Fig. 3C) . Curcumin alone has no effect on cAMP formation (Fig. 3C) . (Fig. 4) , and 10-fold low concentration of EA extract showed more potency rather than ethanol extract.
DISCUSSION
C. longa has been widely used as anti-ulcer remedy in tra- ditional medicine, 3, 4) but its action mechanism is still unclear. In the present study, we have provided a possibility that the C. longa ethanol extract prevent the development of gastric ulcers by blocking H 2 R.
The C. longa extract induced inhibition of cAMP signaling is due to blocking of histamine binding to H 2 R, rather than acceleration of degradation, since the inhibition was observed in the presence of the phosphodiesterase inhibitor Ro20-1724. In addition, the inability of C. longa extract to inhibit b 2 -adrenoceptor mediated cAMP production (Fig. 2B) indicates that the active component(s) of C. longa extract are highly selective, inhibiting only the binding of histamine (or dimaprit) to H 2 R (Fig. 4) . In addition, EA fraction of C. longa extract showed prominent H 2 R antagonistic effect rather than other fractions, suggesting that specific activity was increased (about 4-fold) by successive extraction with EA (Fig. 3B) , indicating that further fractionations and purifications of EA fraction will give a possibility to find active single compound more potent that ranitidine.
In previous report showed that the C. longa extract has curcumin, demethoxycurcumin, bisdemethoxycurcumin, and ar-turmerone. 22) Among these, the curcumin is the major component of C. longa and purified curcumin was more active than either demethoxy-or bisdemethoxycurcumin. 22) In our study, however, pure curcumin showed no significant effect on dimaprit-induced H 2 R signaling in our system (Fig.  3C ). These results demonstrate that unidentified minor constituent in C. longa extract might be associated with H 2 R blocking. There are two previous reports about the constituents in the C. longa EA extract. 23, 24) In these studies, curcumin I (1), curcumin II (2), and curcumin III (3) were isolated as active principles in the EA extract. Therefore, further experiment is required whether these compounds are related with H 2 R regulation and gastric acid secretion. This will help us to determine the critical compound in C. longa extract related with H 2 R blocking and anti-ulcer effect.
Antagonism of H 2 R has been the cornerstone of an immense market for pharmacological treatments of acid-peptic disorders of the gastrointestinal tract.
14) The selective inhibition by C. longa of H 2 R and gastric acid secretion indicate that C. longa extract or its active component(s) may be promising therapeutic candidates for the treatment of gastric ulcers and other H 2 R related diseases. 25) H 2 R antagonists have widely been used for the treatment of gastric-ulcer. Despite H 2 R antagonists are relatively safe drugs, cimetidine, however, is known to interfere with other drugs through hepatic metabolism, the concentration of cocommittant drugs such as warfarin, benzodiazepine tend to be elevated. 26) Nevertheless further experiments are required, we expect that C. longa extract or its active component(s) may replace and reduce the cimetidine related side effects.
In conclusion, our data suggest that C. longa extract shows selective and competitive H 2 R antagonistic effects, indicating a mechanism for the reduction in gastric ulceration observed for C. longa extract. By blocking H 2 R, this extract would provide another remedy for the treatment of gastric ulcers. 
